Los puntos clave no están disponibles para este artículo en este momento.
Changes in body composition accompanied by glucagon-like peptide 1 receptor agonist (GLP-1RA) induced weight loss have drawn much attention. However, fewer studies have reported body composition changes in patients receiving dulaglutide therapy in Chinese population.
Chen et al. (Fri,) studied this question.